Published in Eur J Biochem on July 01, 2004
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol (2008) 1.91
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One (2009) 1.65
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol (2006) 1.60
Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PLoS One (2009) 1.52
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
On the role of melatonin in skin physiology and pathology. Endocrine (2005) 1.43
The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry (2009) 1.43
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech (2008) 1.19
Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood) (2010) 1.18
Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16
A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci U S A (2005) 1.08
CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol (2009) 1.00
Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol (2007) 0.98
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets (2014) 0.95
Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. Hum Mol Genet (2010) 0.93
CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci (2014) 0.89
A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J (2009) 0.89
Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br J Pharmacol (2009) 0.88
Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthood. Psychopharmacology (Berl) (2010) 0.86
An integrated map of corticotropin-releasing hormone signaling pathway. J Cell Commun Signal (2013) 0.82
Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract. Front Neurosci (2011) 0.81
Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20--emerging role of soluble isoforms. J Physiol Pharmacol (2009) 0.81
Activation of Type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON-1N cells: an enterochromaffin cell model. Endocrinology (2010) 0.81
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Reduced expression of CRH receptor type 1 in upper segment human myometrium during labour. Reprod Biol Endocrinol (2009) 0.81
Soluble corticotropin-releasing hormone receptor 2alpha splice variant is efficiently translated but not trafficked for secretion. Endocrinology (2009) 0.80
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. Br J Pharmacol (2009) 0.79
CP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place Preference. PLoS One (2015) 0.75
Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis. Inflammation (2015) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron (1990) 3.70
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A (1993) 2.70
Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol (1988) 2.40
Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci (1999) 2.04
The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci (2002) 1.84
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab (2002) 1.46
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci (2003) 1.37
A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol (1999) 1.21
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab (1998) 1.11
The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin. Endocrinology (1998) 1.08
Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem (2001) 1.06
Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol Endocrinol (2003) 1.01
Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. J Neurochem (1999) 1.01
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett (1998) 0.97
Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Dermatol (2002) 0.95
Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy. J Cell Sci (2003) 0.94
Corticotrophin releasing hormone: its potential for a role in human myometrium. Exp Physiol (2001) 0.91
Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc Natl Acad Sci U S A (2002) 0.90
D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors. Peptides (1998) 0.89
A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem Biophys Res Commun (1994) 0.89
The genomic structure of the rat corticotropin releasing factor receptor. A member of the class II G protein-coupled receptors. J Biol Chem (1996) 0.87
Corticotrophin-releasing hormone receptor type 1: generation and characterization of polyclonal antipeptide antibodies and their localization in pituitary cells and cortical neurones in vitro. J Neuroendocrinol (1996) 0.86
The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s). Biochem Biophys Res Commun (1995) 0.85
Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase. Endocrinology (1999) 0.85
The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy. Mol Genet Metab (2001) 0.84
Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J (2008) 1.84
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab (2011) 1.58
Current concepts of metastasis in melanoma. Expert Rev Dermatol (2008) 1.34
Molecular diagnostics in melanoma. J Am Acad Dermatol (2005) 1.33
Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J (2006) 1.29
Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin. Int J Biochem Cell Biol (2008) 1.27
Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids (2010) 1.23
Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab Dispos (2011) 1.22
20-hydroxyvitamin D₃ inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer Res (2012) 1.18
Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. J Steroid Biochem Mol Biol (2008) 1.17
Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16
Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab (2008) 1.15
Metabolism of vitamin d2 to 17,20,24-trihydroxyvitamin d2 by cytochrome p450scc (CYP11A1). Drug Metab Dispos (2008) 1.13
Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J (2007) 1.12
Inhibition of melanoma metastases by fenofibrate. Arch Dermatol Res (2004) 1.08
Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity. Drug Metab Dispos (2010) 1.07
Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin Cancer Res (2009) 1.03
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol (2008) 1.03
The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol (2007) 1.02
Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin (2007) 1.01
Cultured human dermal fibroblasts do produce cortisol. J Invest Dermatol (2006) 1.00
Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci (2002) 0.99
Role of TRPM in melanocytes and melanoma. Exp Dermatol (2012) 0.98
Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity. Biochem Pharmacol (2012) 0.97
A new steroidal 5,7-diene derivative, 3beta-hydroxyandrosta-5,7-diene-17beta-carboxylic acid, shows potent anti-proliferative activity. Steroids (2009) 0.95
Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Dermatol (2002) 0.95
Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Res (2011) 0.94
Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy. J Cell Sci (2003) 0.94
Melatonin and the hair follicle. J Pineal Res (2008) 0.93
Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol (2002) 0.92
Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol (2013) 0.92
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
Stress-linked cortisol concentrations in hair: what we know and what we need to know. Rev Neurosci (2011) 0.90
A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry (2005) 0.90
The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Exp Dermatol (2010) 0.89
Splenic eumelanin differs from hair eumelanin in C57BL/6 mice. Acta Biochim Pol (2005) 0.89
Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Am J Clin Pathol (2003) 0.88
Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes. J Pineal Res (2008) 0.85
Immuno-histochemical evaluation of solar lentigines: The association of KGF/KGFR and other factors with lesion development. J Dermatol Sci (2010) 0.84
Serotonin metabolism in rat skin: characterization by liquid chromatography-mass spectrometry. Arch Biochem Biophys (2004) 0.83
Biomarkers in melanoma: stage III and IV disease. Expert Rev Mol Diagn (2005) 0.83
Cooling skin cancer: menthol inhibits melanoma growth. Focus on "TRPM8 activation suppresses cellular viability in human melanoma". Am J Physiol Cell Physiol (2008) 0.83
Biomarkers in melanoma: staging, prognosis and detection of early metastases. Expert Rev Mol Diagn (2003) 0.81
Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. Biomark Med (2011) 0.81
Possible mechanisms of hypopigmentation in lichen sclerosus. Am J Dermatopathol (2002) 0.80
Cutaneous metabolism of vitamin B-6. J Invest Dermatol (2003) 0.80
Coming of age of melanogenesis-related proteins. Arch Pathol Lab Med (2002) 0.80
Does p53 regulate skin pigmentation by controlling proopiomelanocortin gene transcription? Pigment Cell Res (2007) 0.80
Biomarkers in melanoma: predisposition, screening and diagnosis. Expert Rev Mol Diagn (2003) 0.80
A novel microarray to evaluate stress-related genes in skin: effect of ultraviolet light radiation. Gene (2004) 0.79
The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi. J Cutan Pathol (2010) 0.79
Nicotinic receptor signaling in nonexcitable epithelial cells: paradigm shifting from ion current to kinase cascade. Focus on "Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases". Am J Physiol Cell Physiol (2010) 0.79
On the role of environmental humidity on cortisol production by epidermal keratinocytes. Exp Dermatol (2014) 0.79
Volar melanotic macules in a gardener: a case report and review of the literature. Am J Dermatopathol (2008) 0.78
A novel translational model of percutaneous fetoscopic endoluminal tracheal occlusion - baboons (Papio spp.). Fetal Diagn Ther (2014) 0.77
What are the clinicopathologic features of matricoma? Am J Dermatopathol (2003) 0.75
Beta-endorphin/mu-opiate receptor system in the skin. J Invest Dermatol (2003) 0.75
KU812 basophils express urocortin, CRH-R, MC1R and steroidogenic enzymes and secrete progesterone. Exp Dermatol (2012) 0.75
Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case-Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors. Am J Dermatopathol (2016) 0.75
Acquired primary cutaneous ganglioneuroma with adipocytic metaplasia: "An end point of melanocytic 'maturation'?" a case report and meta-analysis with comparison to a cross-sectional study of neurotized melanocytic nevi. Am J Dermatopathol (2011) 0.75
Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma. Am J Dermatopathol (2007) 0.75
John Martin Wood (1938-2008)--pioneering biochemist, educator and communicator. Exp Dermatol (2008) 0.75